T-cell immunotherapy with a chimeric receptor against CD38 is effective in eradicating chemotherapy-resistant B-cell lymphoma cells overexpressing survivin induced by BMI-1

T-cell immunotherapy with a chimeric receptor against CD38 is effective in eradicating chemotherapy-resistant B-cell lymphoma cells overexpressing survivin induced by BMI-1

Bibliographic Details
Main Authors: Bhattacharyya, J, Mihara, K, Kitanaka, A, Yanagihara, K, Kubo, T, Takei, Y, Kimura, A, Takihara, Y
Format: Online
Language:English
Published: Nature Publishing Group 2012
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3389163/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3389163/

Similar Items